3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pleural Effusion, Malignant
3
Immunoglobulin Light-chain Amyloidosis
3
Colorectal Neoplasms
3
Breast Neoplasms
3
Mycosis Fungoides
2
Lymphoma, Non-Hodgkin
2
Amyloidosis
2
Waldenstrom Macroglobulinemia
1
Urologic Neoplasms
1
Tuberous Sclerosis
1
Tissue Adhesions
1
Skin Toxicity
1
Sezary Syndrome
1
Ras-wildtype Colorectal Cancer
1
Polyps
1
Polycystic Ovary Syndrome
1
Pleural Neoplasms
1
Pancreatic Neoplasms
1
Pain
1
Neurofibromatosis 2
1
Neoplasms, Second Primary
1
Myoma
1
Menstruation Disturbances
1
Melanoma
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma
1
Interventions
Surveys and Questionnaires
15
Acupuncture Therapy
15
Fentanyl
14
Morphine
13
Acetaminophen
13
Analgesia
12
Lidocaine
11
Ketamine
11
Bupivacaine
11
Methadone
10
Therapeutics
9
Ropivacaine
9
Psychiatric Rehabilitation
9
Oxycodone
9
Hydromorphone
7
Saline Solution
6
Radiotherapy
6
Music Therapy
6
Early Intervention, Educational
6
Zoledronic Acid
5
Yoga
5
Water
5
Methods
5
Control Groups
5
Transcutaneous Electric Nerve Stimulation
4
Therapeutic Touch
4
Physical Therapy Modalities
4
Massage
4
Ketorolac
4
Exercise
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Pain
×
Doxycycline
×
Clear all
NCT01847976
2019-09-06
OTT12-05
Ottawa Hospital Research Institute
Phase 2
Completed
73 enrolled